Immune response to Pneumocystis in simian model of AIDS
艾滋病猿模型对肺孢子菌的免疫反应
基本信息
- 批准号:7325716
- 负责人:
- 金额:$ 58.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-01-01 至 2009-11-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteAddressAlveolarAlveolitisAnimal TestingAnimalsAntibodiesAntibody FormationAntigensB-LymphocytesBiological Response ModifiersBlood specimenBronchoalveolar Lavage FluidCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell physiologyCellsChronicClinicalCollaborationsDataDevelopmentDiseaseDisease ProgressionEventExhibitsExposure toHIVHIV InfectionsHumoral ImmunitiesIL8 geneImmuneImmune System DiseasesImmune responseImmunoglobulin Class SwitchingImmunologyImmunosuppressionImmunotherapyInfectionInfection ControlInfiltrationInflammatoryInflammatory ResponseInjuryInterferon Type IIInterleukin-10Liquid substanceLongitudinal StudiesLungLung InflammationLung diseasesLymphocyteMacacaMeasuresMediatingMediator of activation proteinMemoryModelingMonkeysMorbidity - disease rateNatureNumbersOutcomePathogenesisPathologyPatientsPhasePhysiologicalPhysiologyPlasmaPneumocystisPneumocystis carinii PneumoniaPreventionProductionRecombinantsReportingResearch PersonnelRespiratory physiologyRoleSIVSamplingSpecificityStructure of parenchyma of lungSymptomsT-LymphocyteTestingTherapeutic immunosuppressionTissuesVirusVirus ReplicationWeekWhole Body Plethysmographybasecytokineimmunosuppressedlung injurymacrophagemortalityneutrophilnonhuman primatenovelpathogenperipheral bloodprotective effectpulmonary functionrespiratoryresponse
项目摘要
DESCRIPTION (provided by applicant): Pneumocystis pneumonia (PCP) remains an important cause of morbidity and mortality in HIV-infected patients. CD4+ T cells are critical to clearance of Pneumocystis (Pc), however the role of other immune effectors in controlling this infection or in promoting lung tissue injury is less clear. The presence PC in the lung induces an intense inflammatory response, but the physiologic significance of this response is not well understood, and HIV infection itself can result in inflammatory responses that may cause acute or chronic lung injury. We have developed a novel, non-human primate model of SIV and PC co-infection that closely represents the immune dysfunctions of AIDS, and we propose to use this model to study the interaction of SIV and PC to identify immune mediators that may be exploited to better control PC infection and ameliorate lung injury. The specific aims of this proposal are: 1) To test the hypothesis that the CD8 T cell-predominant lymphocytic alveolitis associated with PC in SIV-infected monkeys and the resultant inflammatory response leads to worsening SIV infection and progression to AIDS. The specificity and function of the infiltrating cells will be determined, and we will determine whether this response has a protective or detrimental effect on disease progression; 2) To test the hypothesis that specific inflammatory responses associated with prolonged PC colonization and infection in SIV-infected monkeys leads to chronic lung injury and worsening pulmonary function. We will measure cellular composition and inflammatory mediators in bronchoalveolar lavage fluid and correlate changes in local immune responses with alterations in lung function. In addition, we will test the effect of local delivery of interleukin-10 in control of lung inflammation and injury; 3) To test the hypothesis that a local humoral response contributes to clearance of PC in SIV-infected monkeys. We will characterize the nature and function of anti-Pc antibodies in serial BAL and plasma samples from SIV/Pc inoculated animals and test the effect of previous exposure to PC antigens and Th2 skewing of the response on the capacity of SIV/Pc-inoculated animals to control the infection. These studies will begin to identify both protective and detrimental immune responses to PC in the context of AIDS immunosuppression and help to characterize novel avenues for immunotherapy and prevention of immune-mediated lung injury in AIDS-associated PC infection.
描述(由申请人提供):肺炎囊肿(PCP)仍然是HIV感染患者发病率和死亡率的重要原因。 CD4+ T细胞对于清除肺炎(PC)至关重要,但是其他免疫效应子在控制这种感染或促进肺组织损伤中的作用尚不清楚。肺中的PC存在引起强烈的炎症反应,但是该反应的生理意义尚不清楚,HIV感染本身可能导致炎症反应,可能导致急性或慢性肺损伤。我们已经开发了一种新型的,非人类的灵长类动物模型的SIV和PC共同感染,该模型密切代表了艾滋病的免疫功能障碍,我们建议使用该模型研究SIV和PC的相互作用,以鉴定可以利用的免疫介体,以更好地控制PC感染并延伸肺损伤。该提案的具体目的是:1)检验以下假设:与PC相关的CD8 T细胞促性淋巴细胞肺泡炎与SIV感染的猴子相关,并且由此产生的炎症反应会导致SIV感染恶化和对AIDS的进展。将确定浸润细胞的特异性和功能,我们将确定该反应对疾病进展是否具有保护性或有害作用。 2)检验以下假设:SIV感染猴子中与长时间PC定植和感染相关的特定炎症反应会导致慢性肺损伤和肺功能恶化。我们将测量支气管肺泡灌洗液中的细胞组成和炎症介质,并将局部免疫反应的变化与肺功能的改变相关。此外,我们将测试白介素10在控制肺部炎症和损伤方面的局部递送的影响; 3)测试局部体液反应有助于在SIV感染的猴子中清除PC的假设。我们将表征来自SIV/PC接种动物的连续BAL和血浆样品中抗PC抗体的性质和功能,并测试先前暴露于PC抗原的接触以及TH2反应对SIV/PC内部动物的能力控制感染的影响。这些研究将在AIDS免疫抑制的背景下开始鉴定对PC的保护性和有害免疫反应,并有助于表征与AIDS相关PC感染中免疫疗法和预防免疫介导的肺损伤的新型途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen A Norris其他文献
Karen A Norris的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen A Norris', 18)}}的其他基金
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
RSV感染临床前模型中妊娠对疫苗诱导免疫和保护的评价
- 批准号:
10269922 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
RSV感染临床前模型中妊娠对疫苗诱导免疫和保护的评价
- 批准号:
10119736 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Prevention and Treatment of Pneumocystis Pneumonia
肺孢子虫肺炎的防治
- 批准号:
10605177 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Prevention and Treatment of Pneumocystis Pneumonia
肺孢子虫肺炎的防治
- 批准号:
10382422 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
RSV感染临床前模型中妊娠对疫苗诱导免疫和保护的评价
- 批准号:
10685614 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
RSV感染临床前模型中妊娠对疫苗诱导免疫和保护的评价
- 批准号:
10470252 - 财政年份:2020
- 资助金额:
$ 58.03万 - 项目类别:
Immunopathogenesis of HIV-associated pulmonary hypertension
HIV相关肺动脉高压的免疫发病机制
- 批准号:
9370162 - 财政年份:2016
- 资助金额:
$ 58.03万 - 项目类别:
Immune dysfunction and pulmonary hypertension in primate model of HIV infection
HIV感染灵长类动物模型中的免疫功能障碍和肺动脉高压
- 批准号:
9404231 - 财政年份:2014
- 资助金额:
$ 58.03万 - 项目类别:
Serologic memory and prevention of Pneumocystis-related COPD in AIDS macaque mode
艾滋病猕猴模型肺孢子虫相关慢性阻塞性肺病的血清学记忆和预防
- 批准号:
8298380 - 财政年份:2011
- 资助金额:
$ 58.03万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
- 批准号:
10706874 - 财政年份:2023
- 资助金额:
$ 58.03万 - 项目类别:
An mHealth implementation strategy to address the syndemic of mental illness, hypertension, and HIV in Uganda
解决乌干达精神疾病、高血压和艾滋病毒综合症的移动医疗实施战略
- 批准号:
10752992 - 财政年份:2023
- 资助金额:
$ 58.03万 - 项目类别:
m6A mRNA reader proteins in the AIDS-opportunistic pathogen Toxoplasma gondii
艾滋病机会致病菌弓形虫中的 m6A mRNA 阅读器蛋白
- 批准号:
10615374 - 财政年份:2023
- 资助金额:
$ 58.03万 - 项目类别:
Host cell membrane perforation during invasion by Toxoplasma gondii
弓形虫入侵过程中宿主细胞膜穿孔
- 批准号:
10587658 - 财政年份:2023
- 资助金额:
$ 58.03万 - 项目类别: